Lee HY - Search Results

1

Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells.

Peng XH, Karna P, O'Regan RM, Liu X, Naithani R, Moriarty RM, Wood WC, Lee HY, Yang L. Peng XH, et al. Among authors: lee hy. Mol Pharmacol. 2007 Jan;71(1):101-11. doi: 10.1124/mol.106.027367. Epub 2006 Oct 11. Mol Pharmacol. 2007. PMID: 17035597

2

Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis.

Lee HY, Oh SH, Woo JK, Kim WY, Van Pelt CS, Price RE, Cody D, Tran H, Pezzuto JM, Moriarty RM, Hong WK. Lee HY, et al. J Natl Cancer Inst. 2005 Nov 16;97(22):1695-9. doi: 10.1093/jnci/dji377. J Natl Cancer Inst. 2005. PMID: 16288123

3

Molecular mechanisms of deguelin-induced apoptosis in transformed human bronchial epithelial cells.

Lee HY. Lee HY. Biochem Pharmacol. 2004 Sep 15;68(6):1119-24. doi: 10.1016/j.bcp.2004.05.033. Biochem Pharmacol. 2004. PMID: 15313408

4

Synthesis and Evaluation of a Novel Deguelin Derivative, L80, which Disrupts ATP Binding to the C-terminal Domain of Heat Shock Protein 90.

Lee SC, Min HY, Choi H, Kim HS, Kim KC, Park SJ, Seong MA, Seo JH, Park HJ, Suh YG, Kim KW, Hong HS, Kim H, Lee MY, Lee J, Lee HY. Lee SC, et al. Among authors: lee j, lee my, lee hy. Mol Pharmacol. 2015 Aug;88(2):245-55. doi: 10.1124/mol.114.096883. Epub 2015 May 14. Mol Pharmacol. 2015. PMID: 25976766

5

A novel antitumor activity of deguelin targeting the insulin-like growth factor (IGF) receptor pathway via up-regulation of IGF-binding protein-3 expression in breast cancer.

Suh YA, Kim JH, Sung MA, Boo HJ, Yun HJ, Lee SH, Lee HJ, Min HY, Suh YG, Kim KW, Lee HY. Suh YA, et al. Among authors: lee sh, lee hy, lee hj. Cancer Lett. 2013 May 10;332(1):102-9. doi: 10.1016/j.canlet.2013.01.022. Epub 2013 Jan 21. Cancer Lett. 2013. PMID: 23348700 Free PMC article.

6

Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.

Jin Q, Feng L, Behrens C, Bekele BN, Wistuba II, Hong WK, Lee HY. Jin Q, et al. Among authors: lee hy. Cancer Res. 2007 Dec 15;67(24):11630-9. doi: 10.1158/0008-5472.CAN-07-2401. Cancer Res. 2007. PMID: 18089792

7

Antiangiogenic effect of deguelin on choroidal neovascularization.

Kim JH, Kim JH, Yu YS, Park KH, Kang HJ, Lee HY, Kim KW. Kim JH, et al. Among authors: lee hy. J Pharmacol Exp Ther. 2008 Feb;324(2):643-7. doi: 10.1124/jpet.107.132720. Epub 2007 Oct 29. J Pharmacol Exp Ther. 2008. PMID: 17967937

8

A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy.

Kim WY, Chang DJ, Hennessy B, Kang HJ, Yoo J, Han SH, Kim YS, Park HJ, Seo SY, Mills G, Kim KW, Hong WK, Suh YG, Lee HY. Kim WY, et al. Among authors: lee hy. Cancer Prev Res (Phila). 2008 Dec;1(7):577-87. doi: 10.1158/1940-6207.CAPR-08-0184. Cancer Prev Res (Phila). 2008. PMID: 19139008 Free PMC article.

9

Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells.

Lee HY, Suh YA, Kosmeder JW, Pezzuto JM, Hong WK, Kurie JM. Lee HY, et al. Clin Cancer Res. 2004 Feb 1;10(3):1074-9. doi: 10.1158/1078-0432.ccr-0833-3. Clin Cancer Res. 2004. PMID: 14871987

10

Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells.

Chun KH, Kosmeder JW 2nd, Sun S, Pezzuto JM, Lotan R, Hong WK, Lee HY. Chun KH, et al. Among authors: lee hy. J Natl Cancer Inst. 2003 Feb 19;95(4):291-302. doi: 10.1093/jnci/95.4.291. J Natl Cancer Inst. 2003. PMID: 12591985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,436 results

Search Page

Filters